+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Hospital & Nursing Home Probiotics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • PDF Icon

    Report

  • 200 Pages
  • April 2025
  • Region: United States
  • Renub Research
  • ID: 6062969
The United States Hospital & Nursing Home Probiotics Market was worth US$ 157 million in 2024 and is anticipated to reach US$ 357.08 million in 2033, expanding at a CAGR of 9.57% from 2025 to 2033. The market is being propelled by heightened awareness of gut health, mounting demand for probiotic-based therapy, and increasing emphasis on infection control and boosting immunity in healthcare centers.

U.S. Hospital And Nursing Home Probiotics Market Forecast Report by Hospital ((Number of Beds (1-199, 200-299, 300-499, 500+), Payer (Medicare, Medicaid, Self-pay, Private, Others), Location (Rural, Urban)), Nursing Home(Number of Beds (Less than 50, 50-99, 100-199, 199+), Payer (Medicare, Medicaid, Dual), Location (Rural, Urban), By Application (Gut Health, Immunity, Wellness, Others), Region And Company Analysis 2025 - 2033.

United States Hospital & Nursing Home Probiotics Market Forecasts

Hospital & nursing home probiotics are advantageous live microbes taken by patients and elderly in-patients in healthcare facilities to promote gut health, immunity, and overall health. These probiotics, usually given in supplements, fortified foods, or beverages, ensure the balance of the gut microbiome, eliminating chances of infections, diarrhea, and antibiotic-related issues.

In the USA, the popularity of probiotics in hospitals and nursing homes has been growing due to increased awareness of their health benefits. Healthcare providers are incorporating probiotics into patient care to enhance digestive health, prevent Clostridium difficile infections, and support immune function. The aging population, particularly in nursing homes, benefits from probiotics as they help manage gastrointestinal disorders and improve nutrient absorption. Besides, the increase in the use of antibiotics has created a need for probiotics to reinstate gut flora. Probiotics are increasingly becoming essential to preventive healthcare in hospitals across the country with research cementing their effectiveness.

Drivers of Growth in the United States Hospital & Nursing Home Probiotics Market

Increased Healthcare Awareness of Gut Health

Nursing homes and hospitals are now aware of the significance of gut health on a patient's general wellbeing. Probiotics support a healthy gut microbiome, lowering the risk of gastrointestinal disorders, antibiotic-associated diarrhea, and infections like Clostridium difficile. With preventive care becoming the priority for healthcare providers, probiotics are now included in treatment protocols, particularly for older patients with compromised digestive systems. The increasing number of clinical studies attesting to the health benefits of probiotics in healthcare facilities is also driving their use in hospitals and nursing homes. May 2023, A recent Ipsos poll for MDVIP reveals that many Americans lack knowledge about the gut microbiome and its effects on health. The survey shows that many people live with digestive issues, with one in five feeling stuck after trying various solutions. Half of Americans have practiced mindful eating for gut health, while two in five have used over-the-counter remedies like laxatives or probiotics. Variations in experiences and perceptions are common across gender, income, and age.

Increasing Elderly Population and Occurrence of Chronic Diseases

An aging population within the United States is growing and increasing elderly patient populations in hospital and nursing facility settings. Seniors are increasingly susceptible to gut issues, reduced immunity, and antibiotic exposure, and thus a beneficial remedy can be probiotics to address such health issues. Moreover, chronic diseases like diabetes, cardiovascular diseases, and gastrointestinal disease are increasing, leading health professionals to employ probiotics as adjunct therapy to treat and promote gut well-being and overall health. Jan 2024, The number of Americans 65 and older is expected to increase from 58 million in 2022 to 82 million in 2050, growing their proportion of the population from 17% to 23%.

Greater Antibiotic Utilization and Microbiome Restoration Need

Antibiotics are widely administered in hospitals and nursing facilities, but overuse of these drugs can upset the gut microbiome, resulting in gastrointestinal disorders. Probiotics restore helpful bacteria, suppressing antibiotic-associated diarrhea and secondary infection risk. With an increasing focus on patient safety and infection prevention, healthcare facilities are adding probiotics as an adjunct therapy to preserve gut equilibrium and improve patient recovery, thus fueling demand in hospitals and nursing homes. In 2.02 trillion antibiotic prescriptions filled from U.S. community pharmacies were prescribed by healthcare providers, approximately 7 prescriptions for each 10 individuals in the outpatient environment.

Challenges in the United States Hospital & Nursing Home Probiotics Market

Regulatory Uncertainty and Lack of Standardization

Although the use of probiotics is becoming increasingly accepted, regulatory issues continue to be a major obstacle. The FDA deems probiotics as dietary supplements, not as pharmaceuticals, which creates disparities in quality control, labeling, and claims of efficacy. Hospitals and nursing facilities need standardized formulations supported by clinical data to maintain patient safety. Uncertainty about guidelines for probiotic use in healthcare facilities makes it challenging for healthcare professionals to safely incorporate them into treatment plans.

Excessive Expenses and Limited Insurance Coverage

Probiotic foods and supplements may be expensive, and widespread implementation in nursing homes and hospitals can be costly. Most insurance companies, such as Medicare and Medicaid, do not cover probiotics as part of standard treatment, which restricts their use for long-term care patients. Furthermore, financial limitations in healthcare facilities can limit the purchase of high-quality probiotic products, limiting market growth even though they have established health benefits.

United States Hospital Probiotics Number of Beds Market

The need for probiotics in hospitals differs based on the number of beds within a facility. Larger hospitals with more beds have greater patient volume, including those that need long-term antibiotic therapy, and thus probiotics are an essential component of patient care. Hospitals with more than 500 beds tend to have specialized nutrition and gastroenterology units that facilitate the use of probiotics. In the meantime, smaller hospitals are increasingly adopting probiotics in their nutritional regimens, particularly for the treatment of digestive disorders. The Definitive Healthcare HospitalView product monitors 7,378 active U.S. hospitals as of April 2024. The hospital facilities are sourced from close to 40 distinct public, private, and proprietary sources. United States Hospital Probiotics Medicare Market
Medicare, which mainly insures elderly and disabled patients, is instrumental in hospitals' use of probiotics. With older patients more susceptible to gastrointestinal problems and infections, hospitals that treat Medicare patients increasingly use probiotics as part of their treatment protocols. Still, limited insurance coverage for probiotic products is a hurdle. Attempts to add probiotics to Medicare-covered nutritional therapies would further stimulate market growth, making them more available to older patients.

United States Urban Hospital Probiotics Market

Urban hospitals also have increased probiotic adoption because they receive improved funding, have access to more advanced medical research, and incorporate new trends in healthcare. Urban hospitals cater to a varied population of patients, including those looking for preventive healthcare options. Urban hospitals having specialized gastroenterology and nutrition programs aids the use of probiotics. Collaborations with pharmaceutical and biotech firms also ease research and development of probiotic formulations specific to hospital use.

United States Nursing Home Probiotics Number of Beds Market

Probiotic demand directly depends on the number of beds in a nursing home. Nursing homes with over 200 beds provide more beds for residents that need constant medical attention, where probiotics form an integral part of dietary and healthcare strategies. Even smaller nursing homes acknowledge the importance of probiotics in strengthening digestive health and immunity, paving the way for incremental market growth. Geriatric and palliative care facilities incorporate probiotics in daily nutritional therapy particularly.

United States Nursing Home Probiotics Medicaid Market

Medicaid is also important in the provision of medical coverage for low-income and elderly patients who live in nursing homes. Though Medicaid pays for most medical bills, probiotic coverage is limited. Nevertheless, with healthcare professionals fighting for probiotics to be included in nutritional support plans, the future offers hope for broader Medicaid coverage. Greater clinical research that proves the cost-effectiveness of probiotics in avoiding infection and hospitalization could lead to increased Medicaid reimbursement in the future.

United States Rural Nursing Home Probiotics Market

Rural nursing homes are confronted with specific challenges to adopt probiotics, such as less access to specialist healthcare professionals and fewer financial opportunities. Nonetheless, knowledge about probiotics is spreading, particularly in areas where the population is aging. Telemedicine and online marketplaces are assisting rural nursing homes in accessing probiotic products, enhancing the digestive and immune health of residents. As healthcare infrastructure develops in rural regions, probiotic implementation in nursing homes will increase progressively.

United States Hospital & Nursing Home Probiotics Gut Health Market

Their function in intestinal health is one of the top reasons that hospitals and nursing facilities are implementing them. Patients who receive treatments that interfere with the gut flora, such as chemotherapy, antibiotic treatment, or abdominal surgery, can greatly benefit from probiotic use. Probiotics depend on older adults in nursing homes with gastrointestinal disease for increased nutrient uptake and relief. The growing awareness of gut health's relationship to overall health fuels demand for probiotics in medical facilities.

United States Hospital & Nursing Home Probiotics Immunity Market

Probiotics enhance immunity, hence their use is crucial in hospitals and nursing homes. Weakened immunity patients, such as postoperative patients, cancer patients on treatment, and the aged, are helped by probiotics that avert infections. The COVID-19 pandemic further raised the profile of immunity-strengthening solutions, leading hospitals and nursing homes to seek probiotics as a complementary patient care option. The trend is forecasted to continue pushing market growth.

North United States Hospital & Nursing Home Probiotics Market

The northern part of the United States is densely populated with top-notch healthcare centers, and therefore, it is a major hospital and nursing home probiotics market. New York, Massachusetts, and Illinois are among the states that have highly developed hospitals focusing on innovative healthcare, including probiotic therapy. The increasing population of elderly individuals in northern states also adds to higher demand for probiotics in nursing homes, where digestive and immune health are the primary concerns among long-term care residents.

South United States Hospital & Nursing Home Probiotics Market

The American South, which has states such as Florida and Texas, also has a high percentage of elderly people, and probiotics are in high demand in nursing homes. Digestive health products are fueled by warm weather and high numbers of retirement communities. Southern healthcare facilities are implementing probiotics in patient recovery programs as well. The market continues to grow with increasing awareness and the more widespread adoption of probiotics in dietary plans and treatment programs in healthcare institutions.

United States Hospital & Nursing Home Probiotics Market Segments

Hospital Probiotics Channel

Number of Beds

1. 1-199
2. 200-299
3. 300-499
4. 500+

Payer

1. Medicare
2. Medicaid
3. Self-pay
4. Private
5. Others

Location

1. Rural
2. Urban

Nursing home Probiotics Channel

Number of Beds

1. Less than 50
2. 50-99
3. 100-199
4. 199+

Payer

1. Medicare
2. Medicaid
3. Dual

Location

1. Rural
2. Urban

Application

1. Gut Health
2. Immunity
3. Wellness
4. Others

Region

1. East
2. West
3. North
4. South

All the Key players have been covered from 4 Viewpoints:

  • Overview
  • Key Persons
  • Recent Development
  • Revenue

Company Analysis

1. American Lifeline Inc.

2. Rising Pharmaceuticals
3. BD
4. Dietary Pros Inc.

5. Dr. Joseph Mercola
6. Probi
7. Lallemand Inc
8. Biocodex
9. Probiotical S.p.A.

10. Protexin

Table of Contents

1. Introduction2. Research & Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. United States Hospital & Nursing Home Probiotics Market
6. Market Share
6.1 By Application
6.2 By Region
7. Hospital Probiotics Channel
7.1 Number of Beds
7.1.1 1-199
7.1.2 200-299
7.1.3 300-499
7.1.4 500+
7.2 Payer
7.2.1 Medicare
7.2.2 Medicaid
7.2.3 Self-pay
7.2.4 Private
7.2.5 Others
7.3 Location
7.3.1 Rural
7.3.2 Urban
8. Nursing home Probiotics Channel
8.1 Number of Beds
8.1.1 Less than 50
8.1.2 50-99
8.1.3 100-199
8.1.4 199+
8.2 Payer
8.2.1 Medicare
8.2.2 Medicaid
8.2.3 Dual
8.3 Location
8.3.1 Rural
8.3.2 Urban
9. Application
9.1 Gut Health
9.2 Immunity
9.3 Wellness
9.4 Others
10. Region
10.1 East
10.2 West
10.3 North
10.4 South
11. Porter’s Five Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Company Analysis
13.1 American Lifeline Inc.
13.1.1 Overview
13.1.2 Key Persons
13.1.3 Recent Development
13.1.4 Revenue
13.2 Rising Pharmaceuticals
13.2.1 Overview
13.2.2 Key Persons
13.2.3 Recent Development
13.2.4 Revenue
13.3 BD
13.3.1 Overview
13.3.2 Key Persons
13.3.3 Recent Development
13.3.4 Revenue
13.4 Dietary Pros, Inc.
13.4.1 Overview
13.4.2 Key Persons
13.4.3 Recent Development
13.4.4 Revenue
13.5 Dr. Joseph Mercola
13.5.1 Overview
13.5.2 Key Persons
13.5.3 Recent Development
13.5.4 Revenue
13.6 Probi
13.6.1 Overview
13.6.2 Key Persons
13.6.3 Recent Development
13.6.4 Revenue
13.7 Lallemand Inc.
13.7.1 Overview
13.7.2 Key Persons
13.7.3 Recent Development
13.7.4 Revenue
13.8 Biocodex
13.8.1 Overview
13.8.2 Key Persons
13.8.3 Recent Development
13.8.4 Revenue
13.9 Probiotical S.p.A.
13.9.1 Overview
13.9.2 Key Persons
13.9.3 Recent Development
13.9.4 Revenue
13.10 Protexin
13.10.1 Overview
13.10.2 Key Persons
13.10.3 Recent Development
13.10.4 Revenue

Companies Mentioned

  • American Lifeline Inc.
  • Rising Pharmaceuticals
  • BD
  • Dietary Pros Inc.
  • Dr. Joseph Mercola
  • Probi
  • Lallemand Inc
  • Biocodex
  • Probiotical S.p.A.
  • Protexin

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information